The global market for Viral Inactivation was estimated at US$627.6 Million in 2023 and is projected to reach US$1.4 Billion by 2030, growing at a CAGR of 11.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Viral Inactivation Market]( "Viral Inactivation Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Viral Inactivation Kits & Reagents segment, which is expected to reach US$777.3 Million by 2030 with a CAGR of a 11.5%. The Viral Inactivation Systems segment is also set to grow at 12.2% CAGR for the next 7-year period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $190.5 Million in 2023, and China, forecasted to grow at an impressive 11.1% CAGR to reach $234.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Viral Inactivation Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Viral Inactivation Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Viral Inactivation Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Charles River Laboratories International, Inc., Clean Cells Inc., Danaher Corporation, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 42 Featured):
- Charles River Laboratories International, Inc.
- Clean Cells Inc.
- Danaher Corporation
- Merck KgaA
- Parker Hannifin Corporation
- Rad Source Technologies, Inc.
- Sartorius AG
- SGS Group (SGS SA)
- Texcell, Inc.
- V.I.P.S. SA
- WuXi AppTec Group
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Viral Inactivation - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Viral Inactivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Viral Inactivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Viral Inactivation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 12: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Vaccines and Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 14: World Historic Review for Vaccines and Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 15: World 16-Year Perspective for Vaccines and Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 16: World Recent Past, Current & Future Analysis for Stem Cell Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 17: World Historic Review for Stem Cell Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 18: World 16-Year Perspective for Stem Cell Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 19: World Recent Past, Current & Future Analysis for Blood and Blood Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 20: World Historic Review for Blood and Blood Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 21: World 16-Year Perspective for Blood and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 22: World Recent Past, Current & Future Analysis for Tissue/ Tissue Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 23: World Historic Review for Tissue/ Tissue Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 24: World 16-Year Perspective for Tissue/ Tissue Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 25: World Recent Past, Current & Future Analysis for Cellular and Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 26: World Historic Review for Cellular and Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 27: World 16-Year Perspective for Cellular and Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 28: World Viral Inactivation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
UNITED STATES
- Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 29: USA Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 30: USA Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 31: USA 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
- TABLE 32: USA Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 33: USA Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 34: USA 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
CANADA
- TABLE 35: Canada Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 36: Canada Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 37: Canada 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
- TABLE 38: Canada Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 39: Canada Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 40: Canada 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
JAPAN
- Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 41: Japan Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 42: Japan Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 43: Japan 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
- TABLE 44: Japan Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 45: Japan Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 46: Japan 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
CHINA
- Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 47: China Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 48: China Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 49: China 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
- TABLE 50: China Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 51: China Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 52: China 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
EUROPE
- Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 53: Europe Recent Past, Current & Future Analysis for Viral Inactivation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 54: Europe Historic Review for Viral Inactivation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 55: Europe 16-Year Perspective for Viral Inactivation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 56: Europe Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 57: Europe Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 58: Europe 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
- TABLE 59: Europe Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 60: Europe Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 61: Europe 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
FRANCE
- Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 62: France Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 63: France Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 64: France 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
- TABLE 65: France Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 66: France Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 67: France 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
GERMANY
- Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 68: Germany Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 69: Germany Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 70: Germany 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
- TABLE 71: Germany Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 72: Germany Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 73: Germany 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
ITALY
- TABLE 74: Italy Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 75: Italy Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 76: Italy 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
- TABLE 77: Italy Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 78: Italy Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 79: Italy 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 80: UK Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 81: UK Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 82: UK 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
- TABLE 83: UK Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 84: UK Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 85: UK 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 87: Rest of Europe Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 88: Rest of Europe 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
- TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 90: Rest of Europe Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 91: Rest of Europe 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 93: Asia-Pacific Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 94: Asia-Pacific 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
- TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 96: Asia-Pacific Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 97: Asia-Pacific 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
REST OF WORLD
- TABLE 98: Rest of World Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 99: Rest of World Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 100: Rest of World 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
- TABLE 101: Rest of World Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 102: Rest of World Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 103: Rest of World 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
Companies Mentioned
- Charles River Laboratories International, Inc.
- Clean Cells Inc.
- Danaher Corporation
- Merck KgaA
- Parker Hannifin Corporation
- Rad Source Technologies, Inc.
- Sartorius AG
- SGS Group (SGS SA)
- Texcell, Inc.
- V.I.P.S. SA
- WuXi AppTec Group
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 173 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 627.6 Million |
| Forecasted Market Value ( USD | $ 1400 Million |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
